145 related articles for article (PubMed ID: 10493415)
1. Azathioprine therapy for acquired myasthenia gravis in five dogs.
Dewey CW; Coates JR; Ducoté JM; Meeks JC; Fradkin JM
J Am Anim Hosp Assoc; 1999; 35(5):396-402. PubMed ID: 10493415
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic crisis after neostigmine administration in a dog with acquired focal myasthenia gravis.
Foy DS; Trepanier LA; Shelton GD
J Vet Emerg Crit Care (San Antonio); 2011 Oct; 21(5):547-51. PubMed ID: 22316202
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous remission in canine myasthenia gravis: implications for assessing human MG therapies.
Shelton GD; Lindstrom JM
Neurology; 2001 Dec; 57(11):2139-41. PubMed ID: 11739846
[TBL] [Abstract][Full Text] [Related]
4. Azathioprine as a single immunosuppressive drug in the treatment of myasthenia gravis.
Cosi V; Lombardi M; Erbetta A; Piccolo G
Acta Neurol (Napoli); 1993 Apr; 15(2):123-31. PubMed ID: 8328322
[TBL] [Abstract][Full Text] [Related]
5. Use of mycophenolate mofetil as a rescue agent in the treatment of severe generalized myasthenia gravis in three dogs.
Abelson AL; Shelton GD; Whelan MF; Cornejo L; Shaw S; O'Toole TE
J Vet Emerg Crit Care (San Antonio); 2009 Aug; 19(4):369-74. PubMed ID: 25164637
[TBL] [Abstract][Full Text] [Related]
6. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.
Palace J; Newsom-Davis J; Lecky B
Neurology; 1998 Jun; 50(6):1778-83. PubMed ID: 9633727
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil treatment in dogs with serologically diagnosed acquired myasthenia gravis: 27 cases (1999-2008).
Dewey CW; Cerda-Gonzalez S; Fletcher DJ; Harb-Hauser MF; Levine JM; Badgley BL; Olby NJ; Shelton GD
J Am Vet Med Assoc; 2010 Mar; 236(6):664-8. PubMed ID: 20225980
[TBL] [Abstract][Full Text] [Related]
8. Clinical forms of acquired myasthenia gravis in dogs: 25 cases (1988-1995).
Dewey CW; Bailey CS; Shelton GD; Kass PH; Cardinet GH
J Vet Intern Med; 1997; 11(2):50-7. PubMed ID: 9127290
[TBL] [Abstract][Full Text] [Related]
9. Adult onset acquired myasthenia gravis in three Great Dane littermates.
Kent M; Glass EN; Acierno M; Shelton GD
J Small Anim Pract; 2008 Dec; 49(12):647-50. PubMed ID: 18684140
[TBL] [Abstract][Full Text] [Related]
10. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
Dau PC; Lindstrom JM; Cassel CK; Denys EH; Shev EE; Spitler LE
N Engl J Med; 1977 Nov; 297(21):1134-40. PubMed ID: 917042
[TBL] [Abstract][Full Text] [Related]
11. Acquired myasthenia gravis associated with a non-invasive thymic carcinoma in a dog.
Stenner VJ; Parry BW; Holloway SA
Aust Vet J; 2003 Sep; 81(9):543-6. PubMed ID: 15086092
[TBL] [Abstract][Full Text] [Related]
12. Third degree atrioventricular block and acquired myasthenia gravis in four dogs.
Hackett TB; Van Pelt DR; Willard MD; Martin LG; Shelton GD; Wingfield WE
J Am Vet Med Assoc; 1995 Apr; 206(8):1173-6. PubMed ID: 7768738
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of treatment with a combination of azathioprine and prednisone in dogs with meningoencephalomyelitis of undetermined etiology: 40 cases (2000-2007).
Wong MA; Hopkins AL; Meeks JC; Clarke JD
J Am Vet Med Assoc; 2010 Oct; 237(8):929-35. PubMed ID: 20946080
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to the acetylcholine receptor in myasthenic dogs.
Garlepp M; Farrow B; Kay P; Dawkins RL
Immunology; 1979 Aug; 37(4):807-10. PubMed ID: 500127
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and prognosis of myasthenia gravis in older people.
Evoli A; Batocchi AP; Minisci C; Di Schino C; Tonali P
J Am Geriatr Soc; 2000 Nov; 48(11):1442-8. PubMed ID: 11083321
[TBL] [Abstract][Full Text] [Related]
16. High-dose immunosuppressive therapy in generalised myasthenia gravis--a 2-year follow-up study.
Heckmann JM; LeePan EB; Eastman RW
S Afr Med J; 2001 Sep; 91(9):765-70. PubMed ID: 11680327
[TBL] [Abstract][Full Text] [Related]
17. Suspected Fluoroquinolone-Induced Exacerbation of Myasthenia Gravis in Dogs.
Guzman KMH; Harkin K
J Am Anim Hosp Assoc; 2023 Sep; 59(5):249-254. PubMed ID: 37708471
[TBL] [Abstract][Full Text] [Related]
18. Azathioprine in the treatment of myasthenia gravis.
Witte AS; Cornblath DR; Parry GJ; Lisak RP; Schatz NJ
Ann Neurol; 1984 Jun; 15(6):602-5. PubMed ID: 6742794
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for acquired myasthenia gravis in dogs: 1,154 cases (1991-1995).
Shelton GD; Schule A; Kass PH
J Am Vet Med Assoc; 1997 Dec; 211(11):1428-31. PubMed ID: 9394894
[TBL] [Abstract][Full Text] [Related]
20. Clinical remission after corticosteroid therapy of acquired myasthenia in three dogs.
Maddison JE; Waelchli-Suter CM; Johnson RP
J Am Vet Med Assoc; 1984 Apr; 184(7):845-8. PubMed ID: 6725125
[No Abstract] [Full Text] [Related]
[Next] [New Search]
